Yorkshire Cancer Research supports clinical studies testing interventions in NHS settings or local communities to improve cancer prevention, early detection, treatment and health equity. The 2027 round particularly welcomes research on multi-cancer early detection tests and GLP-1 receptor agonists.
Eligibility Criteria
- Applicants may be based anywhere in the UK, but studies must recruit participants from Yorkshire.
- Principal applicants must hold, or secure upon funding, substantive employment covering the award.
- Their institutional employment must account for at least 50% of their working time throughout the award.
- Projects must test an intervention in humans and change clinical practice during the study.
- Proposals must address at least one funding priority and demonstrate potential to reduce cancer incidence or improve survival.
- A named lay representative must contribute to application development and project design and delivery.
- Stand-alone diagnostic validation studies and projects focused solely on quality of life are ineligible.
Funding Details
- Total funding pool: £10 million across the round.
- Individual award amount and duration: No fixed maximum; budgets and timelines require justification.
- Direct research costs are eligible; institutional overheads are excluded. Yorkshire Cancer Research
Deadline
- Preliminary applications: December 3, 2026, at 12 noon.
- Invited full applications: March 25, 2027, at 12 noon.
- Funding decisions: September–October 2027.
- Times are UK local time. Yorkshire Cancer Research
Further Information
- Official programme page and applicant guidelines
- Apply through Flexi-Grant
- Contact: research@ycr.org.uk